204 related articles for article (PubMed ID: 11413099)
1. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.
Dixon MF
Gut; 2001 Jul; 49(1):2-4. PubMed ID: 11413099
[No Abstract] [Full Text] [Related]
2. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.
Drnovsek J; Homan M; Zidar N; Smid LM
Radiol Oncol; 2024 Jun; 58(2):186-195. PubMed ID: 38643513
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer prevention from the point of Helicobacter.
Balaban YH; Simşek H; Tatar G
Turk J Gastroenterol; 2014 Aug; 25(4):463-7. PubMed ID: 25254545
[No Abstract] [Full Text] [Related]
5. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
[TBL] [Abstract][Full Text] [Related]
6. Precancerous lesions in the stomach: from biology to clinical patient management.
Rugge M; Capelle LG; Cappellesso R; Nitti D; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):205-23. PubMed ID: 23809241
[TBL] [Abstract][Full Text] [Related]
7. Preventing cancer by disrupting progression of precancerous lesions.
Blot WJ
J Natl Cancer Inst; 2000 Dec; 92(23):1868-9. PubMed ID: 11106670
[No Abstract] [Full Text] [Related]
8. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.
Hwang YJ; Kim N; Lee HS; Lee JB; Choi YJ; Yoon H; Shin CM; Park YS; Lee DH
Aliment Pharmacol Ther; 2018 Feb; 47(3):380-390. PubMed ID: 29193217
[TBL] [Abstract][Full Text] [Related]
9. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
10. Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.
Malik TH; Sayahan MY; Al Ahmed HA; Hong X
J Coll Physicians Surg Pak; 2017 Mar; 27(3):166-172. PubMed ID: 28406776
[TBL] [Abstract][Full Text] [Related]
11. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
12. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
[TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori in gastric carcinoma.
Prabhu SR; Amrapurkar AD; Amrapurkar DN
Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
15. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori. Its relationships and morphological controversies].
Vega-Ramos B; Rodríguez-Moguel L
Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):34-40. PubMed ID: 11464620
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori, achlorhydria and gastric atrophy: what kind of "ménage à trois"?].
Bretagne JF; Heresbach D
Gastroenterol Clin Biol; 1997; 21(2):117-23. PubMed ID: 9161477
[No Abstract] [Full Text] [Related]
18. Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.
Bockerstett KA; Lewis SA; Noto CN; Ford EL; Saenz JB; Jackson NM; Ahn TH; Mills JC; DiPaolo RJ
Gastroenterology; 2020 Dec; 159(6):2116-2129.e4. PubMed ID: 32835664
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view.
Testino G; Cornaggia M; Valentini M
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):357-9. PubMed ID: 10333213
[No Abstract] [Full Text] [Related]
20. Bacteria in the aetio-pathogenesis of gastric cancer: a review.
Houben GM; Stockbrügger RW
Scand J Gastroenterol Suppl; 1995; 212():13-8. PubMed ID: 8578226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
